Table 1.

MAFLD prevalence stratified by different subgroups.

Subgroups	Total Number of Participants	Total Number of Participants with MAFLD	MAFLD Prevalence	χ2	p Value
Overall	9140	2868	31.38%
Sex
Male	3598	1144	31.80%	0.4789	0.489
Female	5542	1724	31.11%
Age at recruitment, years
20–29	540	138	25.56%	32.2759	<0.001
30–39	955	267	27.96%
40–49	1909	601	31.48%
50–59	2299	790	34.36%
60–69	2523	823	32.62%
70–79	914	249	27.24%
Body mass index, kg/m2
<23.0	2288	179	7.82%	1.3e+03	<0.001
23.0–24.9	1888	393	20.82%
≥25.0	4964	2296	46.25%

MAFLD: metabolic associated fatty liver disease.